Prof Juliette Thariat is an expert in Radiotherapy at Centre François Baclesse (France). As of October 2026, ScienceLeadR ranks Juliette Thariat in the top 1% of experts worldwide for Squamous Cell Carcinoma of Head and Neck, Sarcoma and Carcinoma. Juliette Thariat has authored 919 publications, the most recent in 2026, and is an investigator in 30 clinical trials, 10 of them ongoing. SLR score: 3,343 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Juliette Thariat Centre François Baclesse France
3 343 ScienceLeadR Reputation 3343
Network Map

Radiotherapy

Subspecialties: Oncology - Otolaryngology - Nuclear Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2006 - 2026

Source: PubMed

CNRS

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 919

Citations

Citations: 10 583 1st author: 161 Last author: 237 Unique author: 9


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.
PMID 42933448 — neoplasms, nasopharyngeal carcinoma, therapeutics
Lancet Oncol Top journal20260
Preclinical highlights from the 64th Annual Meeting of the Particle Therapy Co-Operative Group (PTCOG 64): Breakthroughs and timelines for potential applications in radiotherapy.
PMID 42933259 — radiotherapy, multiple chronic conditions, radiobiology, therapeutics
Cancer Radiother20260
Navigation-Guided Spatial Mapping of Subclinical Local Invasion in Sinonasal and Nasopharyngeal Malignancies.
PMID 42922403 — carcinoma, squamous cell, probability, hypersensitivity, neoplasms, biopsy, histology, precision medicine, head and neck neoplasms
Int Forum Allergy Rhinol20260
Evaluation of the nutritional and digestive impact of irradiation in nasopharyngeal cancers: the French multicenter retrospective DRAKAR study.
PMID 42892922 — radiotherapy, hospitalization, malnutrition, neoplasms, nasopharyngeal neoplasms, therapeutics, enteral nutrition
Clin Transl Radiat Oncol20260
Quality of surgical reporting and adequacy of surgical treatment in salivary gland cancer: a quality assurance ancillary study of the GORTEC 2016-02 SANTAL trial.
PMID 42617583 — radiotherapy, salivary glands, neoplasms, salivary gland neoplasms, therapeutics, medical oncology
Eur J Surg Oncol20260

Clinical Studies 30

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5

By phase:

N/A 12
Phase 3 12
Phase 2 5
Phase 2/Phase 3 1

By status:

Recruiting 12
Active not recruiting 7
Completed 6
Terminated 4
Not yet recruiting 1

By type:

Interventional 26
Observational 4

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 3
multicentric5to9 3
multicentricup10 16

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

10 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Phase 3 study of NBTXR3 with or without cetuximab in LA HNSCC
2024-520386-31-00 — radiotherapy, cells, cetuximab, carcinoma, squamous cell, drug therapy, aged, squamous cell carcinoma of head and neck, chemotherapy, carcinoma, head, neck
Phase 3Recruiting2025
SPECT CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer
NCT07241273 — oropharyngeal neoplasms, radiotherapy, cells, drainage, quality of life, lymph nodes, carcinoma, squamous cell, single photon emission computed tomography computed tomography, neoplasms, drug-related side effects and adverse reactions, squamous cell carcinoma of head and neck, lymph, tomography, emission-computed, single-photon, head and neck neoplasms, therapeutics, carcinoma, head, neck
N/ANot yet recruiting2026
Flap Sparing in Postoperative Radiotherapy of Oral Cavity Cancers
NCT06798922 — radiotherapy, neoplasms, radiotherapy, adjuvant, therapeutics, mouth, mouth neoplasms, carcinoma
Phase 3Recruiting2025
Prognostic Value of Measuring CtDNA in a Cohort of Patients With Stage III and IV Upper Aero digestive Tract (UADT) Cancer Treated With Curative RADiOtherapy With or Without Concomitant Treatment
NCT06479070 — radiotherapy, cells, blood, circulating tumor dna, blood specimen collection, carcinoma, squamous cell, neoplasms, gastrointestinal tract, research, head and neck neoplasms, therapeutics, dna, carcinoma
N/ARecruiting2024
Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer Watch Your HeaRT
NCT06073509 — radiotherapy, heart diseases, breast neoplasms, heart, arrhythmias, cardiac, data collection, neoplasms, pathology, atrial fibrillation, breast, echocardiography, cardiomyopathies, electrocardiography
N/ARecruiting2023

LeadR Networks

Main global connection map